{
  "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e",
  "docSlug": "cbceb926ed14",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-05-04 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 15,
  "pageCount": 47,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The chart uses a timeline-based annotation style to correlate corporate events with stock performance.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/15",
  "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.08,
        "y": 0.2
      },
      "kind": "callout",
      "text": "An investment in Valeant shares on the day Mike Pearson became CEO has appreciated to ~45x its initial value in seven years including dividend reinvestment",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60bc5377-4c40-4a14-9618-a89ada30987d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.85,
        "x": 0.08,
        "y": 0.335
      },
      "kind": "chart",
      "text": "Valeant total shareholder return from 2/1/2008 to 5/1/2015",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3891811-98e2-41cc-9804-1d21065b94db",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.08,
        "y": 0.845
      },
      "kind": "disclaimer",
      "text": "Note: Chart shows the total shareholder return with the initial share price indexed to 100% for an investment in Valeant Pharmaceuticals International...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45a2f766-ed56-4f36-a534-ece83924f9ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.85,
        "y": 0.36
      },
      "kind": "metric",
      "text": "4,502%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c6d5eea-2ade-47d9-95ca-63aace30cd8c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.08,
        "y": 0.09
      },
      "kind": "title",
      "text": "Valeant’s Platform Strategy Has Created Shareholder Value Over Many Years",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3473a9ab-9a73-479a-beda-7bd9643f34cb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chartjunk Elimination",
      "slug": "chartjunk-elimination",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "0824165b-a743-4a5e-8108-26442116cc1d",
      "evidence": "The slide uses a simple and clear chart to display the total shareholder return.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "164b8a43-23e6-4613-bb24-c050f3a2def6",
      "evidence": "The chart maps corporate events chronologically against stock performance.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 15,
      "beatId": "b3605b89-778c-4fd6-8a6f-f5d0c145c633",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "Data and tables supporting Valeant's platform value and growth",
      "position": 1,
      "confidence": 0.6,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}